Resmed financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

레즈메드NYSE:RMD · New York Stock Exchange · Healthcare

$218.89-1.02%

2026-10-02 close

Resmed's published financial data is dated 2026-10-04. 2025 revenue was $5.15B. 2025 operating profit was $1.69B.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy